CYTOKINETICS, INCORPORATED Cash and Restricted Cash
CYTOKINETICS, INCORPORATED (CYTK) had Cash and Restricted Cash of $258.38 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $258.38M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $132.95M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $125.63M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $228.58M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $258.38M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $132.95M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $125.63M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $228.58M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $76.55M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $74.06M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $95.23M 10-K · filed 2026-02-26 |
| 2023-12-31 | $113.40M 10-K · filed 2025-02-27 |
| 2023-09-30 | $100.07M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $69.01M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $103.22M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $67.18M 10-K · filed 2024-02-28 |
| 2021-12-31 | $112.67M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |